CN Creative Advances Regulatory Initiatives for Its Nicadex(TM) and Intellicig(R) Harm Reduction/Smoking Cessation Products UK Manufacturing Facility Receives "Pharmaceutical Grade" cGMP Designation Plans for Clinical Trial of Nicadex Electronic Inhaler Nicotine Replacement Therapy On Track Will Leverage MHRA...

CN Creative Appoints Chief Financial Officer MANCHESTER, England, April 4, 2012 (GLOBE NEWSWIRE) -- CN Creative, Ltd. (CNC), a healthcare company providing innovative and sustainable solutions to reduce smoking and smoking-related illnesses,...